Đang chuẩn bị liên kết để tải về tài liệu:
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
In many tumour types serumlactate dehydrogenase (LDH) levels proved to represent an indirect marker of tumour hypoxia, neo-angiogenesis and worse prognosis. As we previously reported LDH is an important predictive factor in hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). |